Procter & Gamble (NYSE:PG) Price Target Lowered to $165.00 at BNP Paribas Exane

Procter & Gamble (NYSE:PGGet Free Report) had its price target cut by BNP Paribas Exane from $172.00 to $165.00 in a research note issued on Thursday,MarketScreener reports. The brokerage currently has an “outperform” rating on the stock. BNP Paribas Exane’s target price points to a potential upside of 13.83% from the company’s current price.

Several other research analysts also recently weighed in on PG. TD Cowen reduced their price target on shares of Procter & Gamble from $156.00 to $142.00 and set a “hold” rating for the company in a research report on Wednesday, April 1st. UBS Group reduced their price target on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research report on Tuesday, April 7th. Wells Fargo & Company reduced their price target on shares of Procter & Gamble from $177.00 to $158.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a research report on Friday, March 27th. Finally, Morgan Stanley reduced their price target on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday. Twelve equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $162.37.

Read Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Price Performance

Shares of PG traded up $2.10 during mid-day trading on Thursday, hitting $144.95. 1,697,963 shares of the company were exchanged, compared to its average volume of 10,898,377. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $170.99. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The company has a 50 day moving average of $150.87 and a 200-day moving average of $148.74. The stock has a market cap of $336.86 billion, a price-to-earnings ratio of 21.47, a price-to-earnings-growth ratio of 5.48 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm had revenue of $22.21 billion during the quarter, compared to the consensus estimate of $22.36 billion. During the same quarter in the prior year, the firm earned $1.88 EPS. The company’s revenue for the quarter was up 1.5% on a year-over-year basis. Analysts expect that Procter & Gamble will post 6.96 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Gary A. Coombe sold 36,093 shares of the stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $162.33, for a total value of $5,858,976.69. Following the completion of the sale, the chief executive officer owned 34,994 shares of the company’s stock, valued at $5,680,576.02. This represents a 50.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Chairman Jon R. Moeller sold 162,232 shares of the stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the sale, the chairman directly owned 319,385 shares of the company’s stock, valued at approximately $51,884,093.25. This trade represents a 33.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 348,618 shares of company stock worth $55,462,643 in the last 90 days. Corporate insiders own 0.20% of the company’s stock.

Institutional Trading of Procter & Gamble

Several hedge funds have recently made changes to their positions in PG. Brighton Jones LLC grew its stake in shares of Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after buying an additional 13,617 shares during the period. Taylor Financial Group Inc. boosted its position in shares of Procter & Gamble by 10.6% during the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after purchasing an additional 277 shares during the period. Sivia Capital Partners LLC boosted its position in shares of Procter & Gamble by 19.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock worth $979,000 after purchasing an additional 1,016 shares during the period. Auxano Advisors LLC boosted its position in shares of Procter & Gamble by 10.8% during the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock worth $1,165,000 after purchasing an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. boosted its position in shares of Procter & Gamble by 2.8% during the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock worth $4,809,000 after purchasing an additional 809 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

About Procter & Gamble

(Get Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Further Reading

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.